生物活性 | |||
---|---|---|---|
描述 | (4-NH2)-Exatecan, a topoisomerase inhibitor and a derivative of Exatecan, is being studied for use in the development of antibody-drug conjugates (ADCs), as outlined in US20200306243A1, compound A[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.48mL 0.50mL 0.25mL |
12.39mL 2.48mL 1.24mL |
24.79mL 4.96mL 2.48mL |
参考文献 |
---|
[1]Howard PW, et, al. Compounds and conjugates thereof. US20200306243A1. |